ストックスクリーナーアプリを入手
2.10
3.23%
-0.07
アフターアワーズ：
2.12
0.02
+0.95%
前日終値:
$2.17
開ける：
$2.19
24時間の取引高:
1.29M
Relative Volume:
0.33
時価総額：
$202.16M
収益：
-
当期純損益:
$-67.68M
株価収益率:
-1.2651
EPS:
-1.66
ネットキャッシュフロー:
$-54.24M
1週間 パフォーマンス:
-4.98%
1か月 パフォーマンス:
-16.00%
6か月 パフォーマンス:
+22.81%
1年 パフォーマンス:
-9.48%
1日の値動き範囲:
$2.08
$2.21
1週間の範囲:
$2.00
$2.275
52週間の値動き範囲:
$0.9857
$3.67
Cabaletta Bio Inc Stock (CABA) Company Profile
CABA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CABA
Cabaletta Bio Inc
|
2.10 | 208.90M | 0 | -67.68M | -54.24M | -1.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Cabaletta Bio Inc Stock (CABA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-10 | 再開されました | Jefferies | Buy |
| 2024-12-20 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2024-12-19 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2024-10-10 | 開始されました | UBS | Buy |
| 2024-02-05 | 開始されました | Jefferies | Buy |
| 2023-11-29 | 開始されました | William Blair | Outperform |
| 2023-10-24 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-10-19 | 開始されました | Stifel | Buy |
| 2023-09-05 | 開始されました | Citigroup | Buy |
| 2023-07-18 | 開始されました | Guggenheim | Buy |
| 2023-01-27 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2022-08-30 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-08 | 開始されました | Wells Fargo | Overweight |
| 2021-10-19 | 再開されました | Morgan Stanley | Overweight |
| 2021-06-30 | 開始されました | Mizuho | Buy |
| 2021-01-08 | 開始されました | Chardan Capital Markets | Buy |
| 2020-10-13 | 開始されました | H.C. Wainwright | Buy |
| 2019-11-19 | 開始されました | Cowen | Outperform |
| 2019-11-19 | 開始されました | Evercore ISI | Outperform |
| 2019-11-19 | 開始されました | Morgan Stanley | Overweight |
すべてを表示
Cabaletta Bio Inc (CABA) 最新ニュース
Technical Analysis: Can Cabaletta Bio Inc stock deliver surprise earnings beatJuly 2025 Drop Watch & Real-Time Buy Signal Alerts - moha.gov.vn
Gains Recap: Can Cabaletta Bio Inc. stock hit analyst price targets2025 Volatility Report & Verified Short-Term Plans - ulpravda.ru
Is Cabaletta Bio Inc. stock a top momentum playJuly 2025 Rallies & Risk Controlled Stock Alerts - ulpravda.ru
Aug Intraday: How sustainable is Cabaletta Bio Inc. stock dividend payoutTrade Volume Report & Weekly Breakout Stock Alerts - ulpravda.ru
Is Cabaletta Bio Inc a good long term investmentPrice Volatility Patterns & Free High Profit Capital Plays - earlytimes.in
Cabaletta Bio slides on proposed securities offering - MSN
Cabaletta Bio to Present at Guggenheim’s SMID Cap Biotech Conference - MSN
Cabaletta Bio, Inc. (NASDAQ:CABA) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Smart Money: Is Cabaletta Bio Inc stock a top momentum playMarket Trend Summary & Technical Buy Zone Confirmations - moha.gov.vn
Cabaletta Bio Inc. (CABA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Is Cabaletta Bio Inc. stock gaining market shareLong-Term Investment Plans & Small Budget Capital Growth - Bollywood Helpline
Unraveling Cabaletta Bio Inc.’s Recent Market Moves - StocksToTrade
Bull Bear: Will CHEF stock reach Wall Street targetsWeekly Stock Report & Daily Market Momentum Tracking - moha.gov.vn
Cabaletta Bio, Inc.(NasdaqGS: CABA) added to NASDAQ Biotechnology Index - marketscreener.com
History Review: Is Cabaletta Bio Inc. stock gaining market shareMarket Volume Summary & Daily Technical Forecast Reports - Улправда
Update Report: Is Cabaletta Bio Inc. stock gaining market shareProfit Target & Stepwise Trade Signal Guides - ulpravda.ru
Why Cabaletta Bio Inc. stock remains on watchlistsJuly 2025 Institutional & Weekly High Conviction Trade Ideas - ulpravda.ru
Sentiment Watch: Will Cabaletta Bio Inc. stock recover faster than marketChart Signals & Weekly Chart Analysis and Trade Guides - ulpravda.ru
Will Cabaletta Bio Inc. stock continue upward momentumMarket Rally & Capital Efficiency Focused Ideas - Улправда
Will Cabaletta Bio Inc. stock split again soonQuarterly Investment Review & AI Based Buy and Sell Signals - DonanımHaber
Can Cabaletta Bio Inc. stock deliver surprise earnings beatMarket Sentiment Review & Entry and Exit Point Strategies - DonanımHaber
How Cabaletta Bio Inc. stock benefits from global expansionCPI Data & Expert Curated Trade Setups - bolumsonucanavari.com
Cabaletta Bio Reports Positive Rese-cel Data Across Myositis, SSc, and SLE Trials - MSN
Profit Review: Will Cabaletta Bio Inc. stock recover faster than marketRisk Management & Long Hold Capital Preservation Plans - Улправда
Wells Fargo Downgrades Cabaletta Bio (CABA) - MSN
Is Cabaletta Bio (NASDAQ:CABA) In A Good Position To Invest In Growth? - Yahoo Finance
Cabaletta Bio (CABA) price target increased by 15.31% to 14.41 - MSN
Cabaletta Bio, Inc. $CABA Shares Acquired by Bain Capital Life Sciences Investors LLC - MarketBeat
Cabaletta Bio’s RESET-MG Study: A Potential Game-Changer for Myasthenia Gravis Treatment - MSN
CABA Receives FDA Orphan Status for Myasthenia Gravis Treatment - GuruFocus
Cabaletta Bio, Inc. (NASDAQ:CABA) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Weekly Earnings: Will Cabaletta Bio Inc stock recover faster than marketMarket Sentiment Report & Technical Pattern Based Buy Signals - moha.gov.vn
Cabaletta Bio (CABA) Price Target Increased by 15.31% to 14.41 - Nasdaq
Cabaletta Bio (CABA) Stock Analysis Report | Financials & Insights - Benzinga
Evercore Healthcare Conference - marketscreener.com
Is Cabaletta Bio Inc stock gaining market shareWeekly Trading Summary & Low Risk High Win Rate Picks - BỘ NỘI VỤ
Cabaletta Bio Prices Public Offering to Raise $100 Million - MSN
Cabaletta Bio Advances Rese-cel Pipeline as BLA Submission for Myositis Nears - MSN
Form 8-KCurrent report - ADVFN
Jefferies Financial Group Inc. Takes $3.04 Million Position in Cabaletta Bio, Inc. $CABA - MarketBeat
Cabaletta Bio to Present at Key Global Healthcare and Immunology Conferences - MSN
How supply chain issues affect Cabaletta Bio Inc. stock2025 Winners & Losers & Comprehensive Market Scan Insights - newser.com
Can Cabaletta Bio Inc. stock maintain operating margins2025 Market Overview & Free Real-Time Volume Trigger Notifications - newser.com
Will Cabaletta Bio Inc. stock outperform Nasdaq indexQuarterly Profit Review & High Accuracy Buy Signal Tips - newser.com
How Cabaletta Bio Inc. stock reacts to oil pricesJuly 2025 Momentum & Safe Capital Growth Trade Ideas - newser.com
How Cabaletta Bio Inc. stock performs in rising dollar environmentTrade Risk Assessment & Weekly High Momentum Picks - newser.com
CABALETTA BIO INC (CABA.MX) Stock Price, News, Quote & History - Yahoo! Finance Canada
Why Cabaletta Bio Inc. stock could rally in 2025Bond Market & AI Based Buy/Sell Signal Reports - newser.com
Cabaletta Bio’s Bold Autoimmune Push Raises Big Questions About the Future of CAR T - MyChesCo
Tools to assess Cabaletta Bio Inc.’s risk profileJuly 2025 WrapUp & Precise Entry and Exit Recommendations - newser.com
Is Cabaletta Bio Inc. stock attractive for ETFsLong Setup & Weekly Return Optimization Plans - newser.com
Cabaletta Bio Inc (CABA) 財務データ
収益
当期純利益
現金流量
EPS
0.90%
大文字化:
|
ボリューム (24 時間):